Mexican Regulators Approve Zydus’ Herceptin Biosimilar
The Company Has Secured A Second Biosimilar Approval In Mexico With Trastuzumab
Doubling down on its Latin American strategy, Zydus has managed to snap up a second biosimilar approval in Mexico, paving the way for future launches.
